Health & Biotech
Singular Health is a Western Australian, ASX-listed (ASX: SHG) medical technology company on a mission to create a seamless and integrated healthcare ecosystem where the full value of medical imaging records is unlocked, enabling universal access and promoting interoperability to maximise patient outcomes.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners
News
Top 10 at 11: Helium and lithium are bright spots on a fairly grim ASX morning.
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps and IPO Weekly Wrap: Three – no, FOUR – small caps break 100pc. What a handsome kitty!
News
ASX January winners: The best 50 stocks as ASX S&P reaches record high
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX investors abandon ship after eight straight days on a sea of green
Health & Biotech
ASX Health Stocks: Singular Health shoots 60pc through the roof after breakthrough deal in US
Health & Biotech
ASX Health Winners January: ‘Invest in business not science’, as SHG and PAA top winners list
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Check Up: Earnings season is almost here. Here’s how ASX biotech investors should read the 4C Report
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps and IPO Weekly Wrap: Lotsa pushin’ and shovin’, not a whole lotta movin’
News
Closing Bell: Down on Friday and flat for the week, it’s not called the ALL Ordinaries for nuthin’
Health & Biotech
ASX Health Stocks: Lumos, Singular, and Imricor all jump today after deals and approvals
News
Top 10 at 10: Fatty coal and a healthy software deal
News